Testing effectiveness (Phase 2)UnknownNCT00258336What this trial is testingRituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Favrille 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07809997What this trial is testingPhase I/II Trial of Electroporation-Delivered pBI-4 Vaccine (TriGrid™ PVX4) for Treatment of Women With HPV16-Positive CIN1 or Persistent InfectionWho this might be right forCervical Intraepithelial Neoplasia Grade 1Human Papillomavirus 16 Infection Chang Gung Memorial Hospital 94
Testing effectiveness (Phase 2)UnknownNCT00896519What this trial is testingGM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin LymphomaWho this might be right forLymphoma French Innovative Leukemia Organisation 30
Testing effectiveness (Phase 2)Study completedNCT02113800What this trial is testingSafety and Tolerability of Everolimus as Second-line Treatment in Poorly Differentiated Neuroendocrine Carcinoma / Neuroendocrine Carcinoma G3 (WHO 2010) and Neuroendocrine Tumor G3 - an Investigator Initiated Phase II StudyWho this might be right forPoorly Differentiated Malignant Neuroendocrine CarcinomaNeuroendocrine Carcinoma, Grade 3Neuroendocrine Carcinoma, Grade 1 [Well-differentiated Neuroendocrine Carcinoma] That Switched to G3+2 more AIO-Studien-gGmbH
Testing effectiveness (Phase 2)Looking for participantsNCT06343077What this trial is testingIntratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active SurveillanceWho this might be right forProstate Cancer Patients on Active Surveillance Ashutosh Kumar Tewari 114
Testing effectiveness (Phase 2)Ended earlyNCT00955890What this trial is testingDexrazoxane as a Protective Agent in Anthracycline Treated Breast CancerWho this might be right forBreast Cancer Fudan University 12
Testing effectiveness (Phase 2)Study completedNCT00003874What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Lymphoma or LeukemiaWho this might be right forLeukemiaLymphoma Fred Hutchinson Cancer Center
Not applicableEnded earlyNCT00813501What this trial is testingImmunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other DiseasesWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more City of Hope Medical Center 60
Large-scale testing (Phase 3)Study completedNCT00008359What this trial is testingCaspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer TreatmentWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00238238What this trial is testingRituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to RituximabWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 97
Testing effectiveness (Phase 2)Study completedNCT00474929What this trial is testingSorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm Mayo Clinic 103
Testing effectiveness (Phase 2)Study completedNCT00064311What this trial is testingRavuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00608361What this trial is testingDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more National Cancer Institute (NCI) 80
Not applicableWithdrawnNCT01313104What this trial is testingColposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or CancerWho this might be right forCervical Intraepithelial Neoplasia Grade 1Cervical Intraepithelial Neoplasia Grade 2Cervical Intraepithelial Neoplasia Grade 3+22 more Northwestern University
Testing effectiveness (Phase 2)UnknownNCT00003163What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell CancersWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm Medical College of Wisconsin 10
Not applicableWithdrawnNCT01769911What this trial is testingGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00411086What this trial is testingRituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell LymphomaWho this might be right forLymphoma M.D. Anderson Cancer Center 60
Not applicableEnded earlyNCT00062231What this trial is testingMoxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With CancerWho this might be right forChronic Myeloproliferative DisordersFever, Sweats, and Hot FlashesInfection+8 more European Organisation for Research and Treatment of Cancer - EORTC 351
Testing effectiveness (Phase 2)Study completedNCT00023764What this trial is testingBortezomib in Treating Patients With Lymphoproliferative DisordersWho this might be right forRecurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+1 more National Cancer Institute (NCI) 103
Testing effectiveness (Phase 2)Study completedNCT00004907What this trial is testingChemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's LymphomaWho this might be right forLymphoma Northwestern University